A 4-oxo-1- (3-substituted phenyl) -1, 4-dihydro-1, 8-naphthyridine-3-carboxamide phosphodiesterase-4-inhibitor and a method of preparing same

Details for Australian Patent Application No. 2006308454 (hide)

Owner Merck Frosst Canada Ltd.

Inventors Lacombe, Parick; Gallant, Michel; Dube, Daniel

Agent Spruson & Ferguson

Pub. Number AU-A-2006308454

PCT Pub. Number WO2007/048225

Priority 60/730,621 27.10.05 US

Filing date 23 October 2006

Wipo publication date 3 May 2007

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/4375 (2006.01)

Event Publications

1 May 2008 PCT application entered the National Phase

  PCT publication WO2007/048225 Priority application(s): WO2007/048225

4 November 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006308467-Method and system for high-resolution extraction of quasi-periodic signals

2006308453-IAP BIR domain binding compounds